These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3011678)

  • 21. Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.
    Nation RL; Forrest A
    Adv Exp Med Biol; 2019; 1145():219-249. PubMed ID: 31364081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymyxin B binding sites in Escherichia coli as revealed by polymyxin B-gold labeling.
    Morioka H; Tachibana M; Machino M; Suganuma A
    J Histochem Cytochem; 1987 Feb; 35(2):229-31. PubMed ID: 3025293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. To B or not to B, that is the question: is it time to replace colistin with polymyxin B?
    Kassamali Z; Danziger L
    Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS.
    BARNETT M; BUSHBY SR; WILKINSON S
    Br J Pharmacol Chemother; 1964 Dec; 23(3):552-74. PubMed ID: 14256814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
    Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD
    Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin.
    Hughes B; Madan BR; Parratt JR
    Br J Pharmacol; 1981 Nov; 74(3):701-7. PubMed ID: 6170378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues.
    Craig WA; Turner JH; Kunin CM
    Infect Immun; 1974 Aug; 10(2):287-92. PubMed ID: 4369040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin removal devices for the treatment of sepsis and septic shock.
    Davies B; Cohen J
    Lancet Infect Dis; 2011 Jan; 11(1):65-71. PubMed ID: 21183148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of calcium hydroxide and polymyxin B on endotoxins in root canals.
    Oliveira LD; Leão MV; Carvalho CA; Camargo CH; Valera MC; Jorge AO; Unterkircher CS
    J Dent; 2005 Feb; 33(2):107-14. PubMed ID: 15683891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of antibiotics and intestinal flora associated endotoxin in mice.
    Goris H; de Boer F; van der Waaij D
    Scand J Infect Dis; 1986; 18(1):55-63. PubMed ID: 3008311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of polymyxin B on pertussis vaccine.
    Larter WE; Corrigan JJ; Fulginiti VA
    Am J Dis Child; 1984 Mar; 138(3):281-3. PubMed ID: 6322572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of polymyxins against Escherichia coli in an in-vitro model of the urinary bladder.
    Greenwood D; O'Grady F
    J Med Microbiol; 1977 May; 10(2):255-9. PubMed ID: 192891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacology of polymyxins.
    Ziv G
    J Am Vet Med Assoc; 1981 Oct; 179(7):711-3. PubMed ID: 6281221
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment.
    Walterspiel JN; Kaplan SL; Mason EO
    Pediatr Res; 1986 Mar; 20(3):237-41. PubMed ID: 3010223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues.
    Okimura K; Ohki K; Sato Y; Ohnishi K; Sakura N
    Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1724-30. PubMed ID: 18057747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A; Kasiakou SK; Tam VH; Falagas ME
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin B versus colistin: an update.
    Cai Y; Lee W; Kwa AL
    Expert Rev Anti Infect Ther; 2015; 13(12):1481-97. PubMed ID: 26488563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.